公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo | Huangfu W.-C.; Chao M.-W.; Cheng C.-C.; Wei Y.-C.; Wu Y.-W.; Liou J.-P.; Hsiao G.; Lee Y.-C.; CHIA-RON YANG | Scientific Reports | 4 | 8 | |
2018 | The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells | Tu H.-J.; Lin Y.-J.; Chao M.-W.; Sung T.-Y.; Wu Y.-W.; Chen Y.-Y.; Lin M.-H.; Liou J.-P.; Pan S.-L.; CHIA-RON YANG | Clinical Epigenetics | 21 | 21 | |
2022 | Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment | Lin T.E.; CHIA-RON YANG ; Chou C.-H.; Hsu J.-Y.; Chao M.-W.; Sung T.-Y.; Hsieh J.-H.; Huang W.-J.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 5 | 4 | |
2022 | Identification and analysis of a selective DYRK1A inhibitor | Lin T.E.; Chao M.-W.; HuangFu W.-C.; Tu H.-J.; Peng Z.-X.; Su C.-J.; Sung T.-Y.; Hsieh J.-H.; Lee C.-C.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 6 | 3 | |
2021 | Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach | Chao M.-W.; Lin T.E.; HuangFu W.-C.; Chang C.-D.; Tu H.-J.; Chen L.-C.; Yen S.-C.; Sung T.-Y.; Huang W.-J.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 9 | 8 | |
2015 | Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer | Hsu E.-C.; Kulp S.K.; Huang H.-L.; Tu H.-J.; Chao M.-W.; Tseng Y.-C.; Yang M.-C.; Salunke S.B.; Sullivan N.J.; Chen W.-C.; Zhang J.; Teng C.-M.; WEN-MEI FU ; Sun D.; Wicha M.S.; Shapiro C.L.; Chen C.-S. | Carcinogenesis | 19 | 16 | |
2021 | A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo | Wu Y.-W.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Hsu K.-C.; Liou J.-P.; CHIA-RON YANG ; Yen S.-C.; HuangFu W.-C.; Pan S.-L. | Oncogenesis | 15 | 16 | |
2022 | O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia | Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG ; HuangFu W.-C.; Pan S.-L.; Hsu K.-C. | Phytomedicine | 5 | 5 | |
2017 | An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells | Chao M.-W.; Huang H.-L.; HuangFu W.-C.; Hsu K.-C.; Liu Y.-M.; Wu Y.-W.; Lin C.-F.; Chen Y.-L.; Lai M.-J.; Lee H.-Y.; Liou J.P.; Teng C.-M.; CHIA-RON YANG | Oncotarget | 6 | 5 | |
2022 | Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors | Lin T.E.; Sung L.-C.; Chao M.-W.; Li M.; Zheng J.-H.; Sung T.-Y.; Hsieh J.-H.; CHIA-RON YANG ; Lee H.-Y.; Cho E.-C.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 3 | 3 |